[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"eskd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:eskd":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100636110","comparisons-of-biochemical-and-clinical-outcomes-of-hemodialysis-patients-treated-with-middle-cut-off-dialyzers-versus-high-flux-hemodialysis-or-hemodiafiltration-100636110",false,"NCT07561424","Comparisons Of Biochemical And Clinical Outcomes Of Hemodialysis Patients Treated With Middle Cut-Off Dialyzers Versus High-Flux Hemodialysis Or Hemodiafiltration","CONCORDIA","Inclusion Criteria\n\n* 18 years of age or older\n* Treated at an in-centre dialysis clinic\n* Receiving chronic, maintenance HD","ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","OBSERVATIONAL","The CONCORDIA study is a retrospective, observational study evaluating clinical and biochemical outcomes among patients receiving maintenance hemodialysis with medium cut-off (MCO) dialyzers (Theranova) compared with high-flux hemodialysis (HF-HD) and hemodiafiltration (HDF). Using real-world data from non-DOPPS Theranova sites and the DOPPS cohort as an external control, the study aims to assess whether MCO dialyzers are associated with improved outcomes versus HF-HD and non-inferior outcomes compared with HDF. The primary outcome is all-cause mortality, with secondary outcomes including cardiovascular events, hospitalizations, infections, and laboratory measures related to anemia, mineral metabolism, and inflammation.",[24,25],"ESKD","Dialysis Patients",[27,28],"dialysis","HDF","RECRUITING","2026-04-28",{"date":32,"type":33},"2026-05-01","ACTUAL",{"date":35,"type":33},"2026-02-01",{"date":37,"type":20},"2026-09-01",{"name":39,"class":40},"Arbor Research Collaborative for Health","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":49,"targetDuration":51,"studyType":21,"phases":4,"briefSummary":52,"conditions":53,"keywords":56,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100606848","study-of-diastolic-dysfunction-in-eskd-in-hemodialysis-patient-100606848","NCT07180888","Study of Diastolic Dysfunction in ESKD in Hemodialysis Patient","Inclusion Criteria:\n\n* age between 18 and 65 years not diagnosed by MI able and willing to provide informed consent\n\nExclusion Criteria:\n\nprevious MI arrythmia CHF\n\n\\-",true,{"count":50,"type":20},100,"6 Months","To Asses the prevalence , pattern , and severity of diastolic dysfunction in patients ESKD undergoing regular dialysis and to investigate its correlation with clinical parameters dialysis-related factors and echocardiographic findings",[54,24,55],"Heart Failure","Hemodialysis Patients",[57,58],"echocardiography","dialysis patients","NOT_YET_RECRUITING","2025-09-12",{"date":62,"type":33},"2025-09-18",{"date":64,"type":20},"2025-09-22",{"date":66,"type":20},"2025-10-15",{"name":68,"class":40},"Sohag University"]